Kratom advocates fight FDA crackdown

Published



Opponents of the Food and Drug Administration’s expanding dragnet of the herbal supplement kratom are arguing that the agency is eliminating a vital way to fight the opioid crisis.

Scientists and activists say the agency’s ban on kratom, which is derived from tree leaves native to Southeast Asia, is not scientifically sound and that the agency is taking away a tool that millions of people use to help manage pain and drug withdrawal symptoms.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.